Filter
1549
Text search:
pharmaceutical
needs
Featured
144
414
Language
Document type
756
319
244
84
80
19
19
11
5
5
5
2
Countries / Regions
66
65
64
62
49
41
41
37
34
31
23
22
22
22
21
20
18
18
18
18
18
16
15
15
14
12
12
11
10
10
9
8
7
7
6
6
6
6
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
666
92
80
73
36
25
12
2
Toolboxes
151
149
117
88
72
57
48
39
32
32
29
29
28
24
22
14
13
12
10
7
7
6
4
3
2
Towards the Peoples Health Assembly Book -4
Capability and Performance
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
PMPB/INS-GUIDE/04
Doc. No.: INS/GDL/001-(Annexes)
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Guidelines for social mobilization
TB and poverty; TB and children; TB and women; TB, migrants and refugees; TB and prisons
WHO/CDS/STB/2001.9
Original: English; Distribution: Limited
